While its developmental function is well established, accumulating evidence suggests that OCT4 is aberrantly re-expressed in various cancers, including PCa, where it contributes to tumor initiation, cancer stemness, therapy resistance, and disease progression. Here, POU5F1 is linked to neoplasm.